当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析

泰格医药

(300347)

  

流通市值:301.91亿  总市值:459.10亿
流通股本:5.66亿   总股本:8.61亿

泰格医药(300347)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.10亿元,每股收益0.19元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益2390861.00万元,未分配利润885411.62万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产2872959.29万元,负债482098.29万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入1,564,143,614.716,603,120,162.785,067,615,359.893,358,244,223.39
营业总成本1,421,418,0035,610,048,004.894,026,550,519.062,626,269,846.32
营业利润144,504,382.4664,419,011.511,084,995,900.89687,069,420.22
利润总额143,625,342.84664,461,508.31,087,064,971.75690,093,172.97
净利润109,980,847.86447,831,286.97903,135,476.96557,578,693.92
其他综合收益5,329,777.35-30,367,462.62-50,709,884.36-30,370,935.25
综合收益总额115,310,625.21417,463,824.35852,425,592.6527,207,758.67
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计5,895,369,481.16,299,685,225.866,547,520,834.957,646,634,878.7
非流动资产合计22,834,223,468.1222,371,330,561.323,729,071,186.3522,770,481,531.14
资产总计28,729,592,949.2228,671,015,787.1630,276,592,021.330,417,116,409.84
流动负债合计3,635,724,221.913,661,852,465.124,795,257,756.835,332,415,803.11
非流动负债合计1,185,258,688.81944,684,135.451,062,535,113.271,017,224,456.84
负债合计4,820,982,910.724,606,536,600.575,857,792,870.16,349,640,259.95
归属于母公司股东权益合计20,529,274,699.720,670,653,449.7221,064,966,698.7520,765,168,106.14
股东权益合计23,908,610,038.524,064,479,186.5924,418,799,151.224,067,476,149.89
负债和股东权益合计28,729,592,949.2228,671,015,787.1630,276,592,021.330,417,116,409.84
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计1,652,480,592.316,960,762,922.994,993,719,526.643,167,414,281.9
经营活动现金流出小计1,454,545,978.135,863,761,019.254,414,949,916.692,990,085,897.19
经营活动产生的现金流量净额197,934,614.181,097,001,903.74578,769,609.95177,328,384.71
投资活动现金流入小计148,932,353.842,171,059,961.71667,411,884.05313,942,039.75
投资活动现金流出小计806,801,592.26,910,182,376.126,390,528,783.584,935,752,742.45
投资活动产生的现金流量净额-657,869,238.36-4,739,122,414.41-5,723,116,899.53-4,621,810,702.7
筹资活动现金流入小计617,956,0003,586,116,727.863,012,671,977.211,601,118,629.06
筹资活动现金流出小计721,821,806.55,288,526,955.493,284,673,663.161,394,908,618.55
筹资活动产生的现金流量净额-103,865,806.5-1,702,410,227.63-272,001,685.95206,210,010.51
汇率变动对现金及现金等价物的影响4,959,416.33-6,916,778.71-21,705,538.241,473,866.18
现金及现金等价物净增加额-558,841,014.35-5,351,447,517.01-5,438,054,513.77-4,236,798,441.3
期末现金及现金等价物余额1,489,652,838.492,048,493,852.841,961,886,856.083,163,142,928.55
最新报告期:2025-06-19
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华兴证券赵冰1.562.042.902025-06-19
中泰证券崔少煜,祝嘉琦1.251.461.722025-05-11
浙商证券孙建,郭双喜1.181.401.702025-04-14
兴业证券孙媛媛,黄翰漾1.241.431.652025-04-02
中信建投刘若飞,贺菊颖1.401.762.172025-04-02
TOP↑